Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection - PubMed (original) (raw)
Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection
M Marmor et al. J Acquir Immune Defic Syndr. 2001.
Abstract
Objective: To investigate evidence for resistance to HIV-1 infection associated with the heterozygous genotype CCR5-+/Delta32 and with the homozygous genotype CCR5-Delta32/Delta32, which results in a nonfunctional CCR5 receptor.
Design: Cohort study of initially HIV-seronegative high-risk individuals from eight different cities. Enrollment data were analyzed to investigate the association of demographic factors and risk behaviors with CCR5 genotypes on the assumption that increased genotype prevalence among persons with histories of longer or more intensive exposure to HIV would indicate HIV resistance associated with that genotype. Longitudinal data were analyzed to investigate the association of HIV seroincidence with CCR5 genotypes. The cohort of 2996 individuals included 1892 men who have sex with men (MSM), 474 male injection drug users (IDUs), 347 women at heterosexual risk, and 283 female IDUs.
Measurements: CCR5 genotype, HIV serostatus, demographic factors, and risk behaviors during the 6 months before enrollment, followed by measurement of HIV seroincidence during the subsequent 18 months (for men) and 24 months (for women).
Results: Forty (1.3%) subjects were homozygous CCR5-Delta32/Delta32 and 387 (12.9%) were heterozygous CCR5-+/Delta32. All but 1 CCR5-Delta32/Delta32 individuals and 51 CCR5-+/Delta32 individuals were Caucasian. Among 1531 Caucasian MSM, CCR5-+/Delta32 individuals were present more frequently (22.3%) among those reporting unprotected receptive anal intercourse than among those not reporting this risk (15.9%) (p =.002), suggesting a selective advantage of the heterozygous genotype. CCR5-+/Delta32 individuals also had a significantly reduced relative risk of HIV seroconversion adjusted for unprotected receptive anal intercourse compared with CCR5-/+ individuals (relative risk = 0.30, 95% confidence interval [CI]: 0.08-0.97). CCR5-Delta32/Delta32 prevalence among Caucasian MSM was significantly associated with age among subjects recruited from high HIV seroprevalence cities (New York City and San Francisco) (odds ratio [OR] for each decade increase in age = 2.57, CI: 1.56-4.21) but not among those recruited from lower HIV prevalence sites (Boston, Chicago, Philadelphia, Seattle, and Providence/Pawtucket, Rhode Island) (OR = 1.20, CI: 0.75-1.89).
Conclusions: Cross-sectional and longitudinal analyses indicated that among high-risk HIV seronegative MSM, CCR5-+/Delta32 and CCR5-Delta32/Delta32 are associated with protection against HIV infection. These findings imply that strategies aimed at reducing susceptibility to HIV infection by blocking CCR5 receptor sites need not seek blockage of all receptor sites to achieve an imperfect but substantial degree of protection.
Similar articles
- Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
Donyavi T, Bokharaei-Salim F, Nahand JS, Garshasbi S, Esghaei M, Sadeghi M, Jamshidi S, Khanaliha K. Donyavi T, et al. J Med Virol. 2020 Aug;92(8):1158-1164. doi: 10.1002/jmv.25658. Epub 2020 Jan 17. J Med Virol. 2020. PMID: 31854469 - Phenotypic expressions of CCR5-delta32/delta32 homozygosity.
Nguyêñ GT, Carrington M, Beeler JA, Dean M, Aledort LM, Blatt PM, Cohen AR, DiMichele D, Eyster ME, Kessler CM, Konkle B, Leissinger C, Luban N, O'Brien SJ, Goedert JJ, O'Brien TR. Nguyêñ GT, et al. J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):75-82. doi: 10.1097/00042560-199909010-00010. J Acquir Immune Defic Syndr. 1999. PMID: 10534150 - Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
Nkenfou CN, Mekue LC, Nana CT, Kuiate JR. Nkenfou CN, et al. BMC Res Notes. 2013 Jul 23;6:288. doi: 10.1186/1756-0500-6-288. BMC Res Notes. 2013. PMID: 23880174 Free PMC article. - HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.
Sheppard HW, Celum C, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP. Sheppard HW, et al. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):307-13. doi: 10.1097/00126334-200203010-00013. J Acquir Immune Defic Syndr. 2002. PMID: 11873082 Review. - HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
Smoleń-Dzirba J, Rosińska M, Janiec J, Beniowski M, Cycoń M, Bratosiewicz-Wąsik J, Wąsik TJ. Smoleń-Dzirba J, et al. AIDS Rev. 2017 Dec;19(4):219-230. AIDS Rev. 2017. PMID: 28534889 Review.
Cited by
- Autophagy-enhancing ATG16L1 polymorphism is associated with improved clinical outcome and T-cell immunity in chronic HIV-1 infection.
Schreurs RRCE, Koulis A, Booiman T, Boeser-Nunnink B, Cloherty APM, Rader AG, Patel KS, Kootstra NA, Ribeiro CMS. Schreurs RRCE, et al. Nat Commun. 2024 Mar 28;15(1):2465. doi: 10.1038/s41467-024-46606-z. Nat Commun. 2024. PMID: 38548722 Free PMC article. - Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers.
Hokello J, Tyagi P, Dimri S, Sharma AL, Tyagi M. Hokello J, et al. Viruses. 2023 Jun 13;15(6):1362. doi: 10.3390/v15061362. Viruses. 2023. PMID: 37376660 Free PMC article. Review. - Immunogenetic Predisposition to SARS-CoV-2 Infection.
Lehmann C, Loeffler-Wirth H, Balz V, Enczmann J, Landgraf R, Lakowa N, Gruenewald T, Fischer JC, Doxiadis I. Lehmann C, et al. Biology (Basel). 2022 Dec 25;12(1):37. doi: 10.3390/biology12010037. Biology (Basel). 2022. PMID: 36671730 Free PMC article. - Agent-based model projections for reducing HIV infection among MSM: Prevention and care pathways to end the HIV epidemic in Chicago, Illinois.
Vermeer W, Gurkan C, Hjorth A, Benbow N, Mustanski BM, Kern D, Brown CH, Wilensky U. Vermeer W, et al. PLoS One. 2022 Oct 17;17(10):e0274288. doi: 10.1371/journal.pone.0274288. eCollection 2022. PLoS One. 2022. PMID: 36251657 Free PMC article. - CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.
Jasinska AJ, Pandrea I, Apetrei C. Jasinska AJ, et al. Front Immunol. 2022 Jan 27;13:835994. doi: 10.3389/fimmu.2022.835994. eCollection 2022. Front Immunol. 2022. PMID: 35154162 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- AI27742/AI/NIAID NIH HHS/United States
- M01-RR00096/RR/NCRR NIH HHS/United States
- N01-AI-35176/AI/NIAID NIH HHS/United States
- N01-AI-45200/AI/NIAID NIH HHS/United States
- N01-AI-45202/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical